Mannatech Inc (MTEX) Financial Statements
Industry: Medicinal Chemicals & Botanical Products
In fiscal 2025, Mannatech reported revenue of $108.0M, down 8.3% from $117.9M the year before. Net income was -$15.2M (a -14.1% net margin), or -$8.00 per diluted share. Gross margin was 74.9% and operating margin was -0.4%. Operating activities generated -$3.0M of cash, leaving -$4.3M of free cash flow. At fiscal year end, Mannatech held $30.0M in total assets against $35.2M in total liabilities, including $6.2M of cash and equivalents.
Open the full interactive Mannatech financials → Quarterly statements, key ratios, valuation history and price charts.
Mannatech Key Stats
| Share Price | $7.56 |
|---|---|
| Market Cap | $14.6M |
| Revenue YoY Growth | -8.3% |
| 52-Week Range | $3.95 – $10.19 |
| Shares Outstanding | 1.9 million (basic, 2026 Q2) |
Mannatech Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $151.4M | $159.8M | $137.2M | $132.0M | $117.9M | $108.0M |
| Gross Profit | $115.9M | $125.6M | $104.1M | $102.9M | $91.5M | $81.0M |
| Operating Income | $4.5M | $9.0M | -$405,000 | -$964,000 | $1.4M | -$426,000 |
| Pre-Tax Income | $5.7M | $8.9M | -$479,000 | -$1.1M | $3.7M | -$2.9M |
| Income Tax | -$536,000 | -$950,000 | $4.0M | $1.1M | $1.2M | $12.3M |
| Net Income | $6.3M | $9.8M | -$4.5M | -$2.2M | $2.5M | -$15.2M |
| Diluted EPS | $2.77 | $4.71 | -$2.35 | -$1.20 | $1.32 | -$8.00 |
Mannatech Quarterly Results
| 2025 Q1 | 2025 Q3 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $26.6M | $29.2M | $24.9M | $26.6M |
| Net Income | -$1.5M | $1.9M | $950,000 | $1.0M |
| Diluted EPS | -$0.80 | $1.01 | $0.49 | $0.53 |
Mannatech Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $22.2M | $24.2M | $13.8M | $7.7M | $11.4M | $6.2M |
| Current Assets | $42.5M | $42.8M | $35.0M | $27.7M | $26.1M | $20.6M |
| Total Assets | $65.3M | $59.6M | $49.1M | $41.2M | $36.1M | $30.0M |
| Current Liabilities | $32.0M | $30.1M | $29.8M | $25.8M | $20.9M | $18.7M |
| Total Long-Term Debt | $2.8M | $405,000 | $300,000 | $440,000 | $3.0M | $2.8M |
| Total Liabilities | $39.4M | $35.2M | $35.0M | $30.7M | $27.4M | $35.2M |
| Shareholders' Equity | $26.0M | $24.4M | $14.2M | $10.5M | $8.6M | -$5.2M |
Mannatech Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $6.0M | $10.8M | -$2.6M | -$2.4M | $2.3M | -$3.0M |
| Cash From Investing | -$947,000 | -$650,000 | -$1.1M | -$747,000 | -$285,000 | -$1.4M |
| Cash From Financing | -$9.9M | -$9.3M | -$4.3M | -$1.9M | $2.0M | -$561,000 |
| Free Cash Flow | $5.1M | $10.1M | -$3.7M | -$3.1M | $2.0M | -$4.3M |
Figures from Mannatech's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Mannatech financials page for every line item.
Mannatech Company Profile
| Ticker | MTEX |
|---|---|
| Exchange | Nasdaq |
| Industry | Medicinal Chemicals & Botanical Products |
| Headquarters | Flower Mound, Texas |
| Incorporated in | Texas |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001056358 |
Frequently Asked Questions
What was Mannatech's revenue in fiscal 2025?
Mannatech (MTEX) reported revenue of $108.0M for fiscal 2025.
What is Mannatech's annual revenue history?
Mannatech's annual revenue by fiscal year: 2020: $151.4M; 2021: $159.8M; 2022: $137.2M; 2023: $132.0M; 2024: $117.9M; 2025: $108.0M.
What was Mannatech's net income in fiscal 2025?
Mannatech reported net income of -$15.2M for fiscal 2025.
What was Mannatech's earnings per share (EPS) in fiscal 2025?
Mannatech's diluted EPS was -$8.00 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Mannatech generate in fiscal 2025?
Mannatech generated -$4.3M of free cash flow in fiscal 2025.
What was Mannatech's revenue last quarter?
In its most recent reported quarter (2026 Q2), Mannatech reported revenue of $26.6M.
How much debt does Mannatech have?
Mannatech reported $2.8M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Mannatech are outstanding?
Mannatech reported a weighted average of 1.9 million basic shares outstanding in 2026 Q2.
What is Mannatech's market cap?
Based on its latest closing price, Mannatech (MTEX) has a market capitalization of about $14.6M.
When does Mannatech's fiscal year end?
Mannatech's fiscal year end, as registered with the SEC, is December 31.
Where is Mannatech headquartered?
Mannatech lists its business address in Flower Mound, Texas in its SEC filings.
Mannatech Competitors & Similar Companies
See all 11 Medicinal Chemicals & Botanical Products companies →